Literature DB >> 6407771

Human hepatocyte-mediated mutagenesis and DNA repair activity.

S C Strom, D L Novicki, A Novotny, R L Jirtle, G Michalopoulos.   

Abstract

Combined cultures of human hepatocytes and human fibroblasts constitute a system composed entirely of normal human cells that can be used to investigate the mutagenicity of chemicals requiring metabolic activation. Addition of diethylnitrosamine (DEN) to this system resulted in mutations at the hypoxanthine-guanine phosphoribosyltransferase locus of the human fibroblasts. In separate experiments with cultures of hepatocytes alone, DEN induced unscheduled DNA synthesis (UDS) in the human hepatocytes. A comparative analysis of UDS and hepatocyte-mediated mutagensis indicates a great degree of similarity between the human and previously studied rat hepatocytes in their response to DEN in vitro.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407771     DOI: 10.1093/carcin/4.6.683

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  The hepatocyte primary culture/DNA repair test using hepatocytes from several species.

Authors:  C A McQueen; G M Williams
Journal:  Cell Biol Toxicol       Date:  1987-06       Impact factor: 6.691

2.  Drug metabolising activity of freshly isolated human hepatocytes.

Authors:  L B Tee; T Seddon; A R Boobis; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

3.  A comparison of the inhibition of deacetylase in primary cultures of rat and human hepatocytes effecting metabolism and DNA-binding of 2-acetylaminofluorene.

Authors:  D K Monteith; S C Strom
Journal:  Cell Biol Toxicol       Date:  1990-07       Impact factor: 6.691

4.  Human hepatocyte primary cultures in toxicity assessment.

Authors:  G Brambilla; A Martelli
Journal:  Cytotechnology       Date:  1993-01       Impact factor: 2.058

Review 5.  Liver cell models in in vitro toxicology.

Authors:  A Guillouzo
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.